News

KHB Group Unveils the Next-Gen MF200 Analyzer for Vets

KHB Group Unveils the Next-Gen MF200 Analyzer for Vets

Introducing the Enhanced FOCUS PEGASUS MF200 Analyzer

In a groundbreaking move for veterinary diagnostics, Guangzhou Focus Biotechnology Co., Ltd., a subsidiary of KHB Group, has unveiled the new FOCUS PEGASUS MF200 Automatic Multifunctional Veterinary Analyzer. This state-of-the-art system is designed to enhance efficiency and reliability in the veterinary field, providing innovative solutions for point-of-care testing.

Multifunctional Features for Every Veterinary Practice

The MF200 combines a variety of crucial testing functionalities into a singular, compact analyzer. By integrating Biochemistry, Electrolytes, Coagulation, and Immunofluorescence tests, this device ensures that veterinary professionals can perform multiple essential tests on just one machine. This not only streamlines the workflow but also significantly improves the quality and speed of diagnostics available to animal care specialists.

Smart Point-of-Care Testing

The FOCUS PEGASUS MF200 is equipped with advanced features that promote smart point-of-care testing. It offers a one-step operation that delivers results in just 10 minutes, a remarkable time frame that emphasizes the need for quick diagnostics in veterinary practices. Furthermore, its extensive test menu covers over 90% of routine pet diagnostics.

Animal-Friendly and Efficient Design

Recognizing the importance of animal welfare, the MF200 is designed to require only a minimal sample size of just 100 ?L. This approach ensures that sampling is fast, safe, and minimizes stress for both the animal and the veterinary staff. With this enhanced sampling method, veterinarians can perform their work with greater confidence, reducing the incidence of animal distress during testing.

Reducing Errors with an Intelligent System

One of the standout features of the MF200 is its intelligent system, which automates essential processes such as dilution, centrifugation, and QR code scanning. By minimizing the need for manual input, this analyzer helps to reduce human error and enhance the consistency of results. With a user-friendly interface, veterinarians are empowered to deliver accurate and reliable diagnostics with ease.

KHB's Commitment to Innovation in Veterinary Care

KHB Group has made significant strides in veterinary diagnostics since its inception. The FOCUS PEGASUS MF200 is set to be featured at MEDICA 2025, highlighting KHB's ongoing commitment to advancing technology in animal healthcare. Li Ming, CEO of KHB Group, stated, "The MF200 represents the next evolution in smart veterinary testing — a compact solution that truly redefines diagnostic efficiency." Through such innovations, KHB aims to provide veterinary professionals with the tools they need to achieve speed and precision in their diagnostics.

About KHB Group

Shanghai Kehua Bio-engineering Co., Ltd. (KHB) has established itself as a leader in the in vitro diagnostics (IVD) market. With a focus on immune diagnosis, biochemical diagnosis, molecular diagnosis, and point-of-care testing (POCT), KHB has evolved into a high-tech enterprise since its founding in 1981. Listed on the Shenzhen Stock Exchange in 2004, KHB continues to grow and innovate in the medical diagnostic field.

Through its subsidiary, Guangzhou Focus Biotechnology Co., Ltd., which specializes in veterinary POCT solutions, KHB is committed to becoming a global leader in animal healthcare diagnostics. The launch of the FOCUS PEGASUS MF200 is just one example of how the company strives to improve veterinarian services worldwide.

Frequently Asked Questions

What is the FOCUS PEGASUS MF200?

The FOCUS PEGASUS MF200 is an advanced veterinary analyzer that incorporates multiple testing capabilities into one device, optimizing diagnostic efficiency for veterinarians.

How quickly can test results be obtained using the MF200?

The MF200 provides results in as little as 10 minutes, allowing veterinarians to make timely decisions for animal care.

What types of tests can the MF200 perform?

The MF200 offers a broad test menu that includes Biochemistry, Electrolytes, Coagulation, and Immunofluorescence tests, covering most routine diagnostics in veterinary practices.

How does the MF200 ensure minimal stress for animals during testing?

The analyzer requires only a small sample size (100 ?L), which makes the sampling process faster and less stressful for animals.

Where can I find more information about KHB Group?

For additional details about KHB Group and its products, you can visit KHB's official website and their social media pages.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 19

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 180

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Tony Perkins' Church Tour amid Controversial Vote

Updated Category News Views 89

Lining the pews in Missouri and Kansas, folks are about to get a powerful dose of Tony Perkins this weekend. The Family Research Council President is driving straight into the heart of both spiritual and political fervor at a couple of church stops on Sunday, October 25—right on the doorstep of a crucial vote in Missouri. Taking the Stage in a Time of Tension Now,...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 85

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 67

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
NEXT Properties Exchange Offers: The Full Breakdown

Updated Category News Views 103

What's the Deal with These Exchange Offers? You know, nothing says 'we're changing things up' like an exchange offer. So what did NEXT Properties do? Well, they laid down two offers for the books on their outstanding 6.950% and 6.390% senior notes, due in 2044 and 2050, respectively. These are getting swapped out for some fresh 7.731% senior sustainability-linked notes...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 35

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 95

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
CASEKOO's Spooky Collectibles: Postcards Meet Cases

Updated Category News Views 77

Here we go with an unexpected twist in the phone accessory game. CASEKOO decided it's time to mix things up this Halloween with something as peculiar as it is intriguing: limited-edition Spooky Season Commemorative Postcards. A Spooky Strategy to Celebrate Ten Years Get this, folks—CASEKOO's looking to mark a decade in the business with more than just confetti and a...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 150

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading

Top 5 Most Recently Viewed Articles

Emerging Trends in the Quantum Key Distribution Sector

Updated Category News Views 357

Overview of Quantum Key Distribution Growth The global Quantum Key Distribution (QKD) market is poised for significant growth. Analysts anticipate that the market will expand from USD 0.48 billion in 2024 to USD 2.63 billion by 2030, representing a remarkable Compound Annual Growth Rate (CAGR) of 32.6%. This forecast underscores the urgency for organizations to bolster...

Continue Reading
Understanding the Growing Cloud Endpoint Protection Market

Updated Category News Views 170

In 2023, the cloud endpoint protection market stood at about USD 5.1 billion, but oh boy, was that just the start of a massive wave. Fast forward to projections for 2033, and we’re talking around USD 23.6 billion—a staggering compound annual growth rate (CAGR) of roughly 22.7%. What does this tell us? The need for robust endpoint protection ain't slowing down anytime...

Continue Reading
Hartford HealthCare Cancer Institute Achieves MSK Care Partner Status

Updated Category News Views 129

Historic Milestone in Cancer Care Hartford HealthCare Cancer Institute has made a remarkable achievement by becoming the first healthcare system in the United States to be designated as a Care Partner of Memorial Sloan Kettering Cancer Center (MSK). This prestigious recognition highlights Hartford HealthCare's commitment to providing exceptional oncology care and elevates...

Continue Reading
Actinogen Advances with New Drug Name for Alzheimer's Treatment

Updated Category News Views 330

Actinogen Medical Introduces Emestedastat for Xanamem Actinogen Medical Limited (ASX: ACW) has announced a significant milestone in its Alzheimer's treatment journey with the introduction of the nonproprietary name 'emestedastat' for its leading drug, Xanamem. This recognition by the World Health Organization (WHO) places Actinogen at the forefront of clinical innovation...

Continue Reading
Gilead Sciences Insider Moves Spark Investor Interest

Updated Category News Views 146

Insider Activity at Gilead Sciences: Key Updates Recently, a significant transaction was reported by Jeffrey Bluestone, a Board Member at Gilead Sciences (NASDAQ: GILD). In a filing with the SEC, it was revealed that Bluestone exercised stock options for a total of 5,000 shares. This transaction was valued at $296,250, drawing important attention from investors and market...

Continue Reading